Apollo Commercial Real Estate Finance, Inc. Announces Dates

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Apollo Commercial Real Estate Finance, Inc. Announces Dates for First Quarter 2013 Earnings Release and Conference Call

NEW YORK, NY--(Marketwired - Apr 10, 2013) -  Apollo Commercial Real Estate Finance, Inc. (the "Company" or "ARI") ( NYSE : ARI ) today announced the Company will hold a conference call to review its first quarter financial results on Thursday, May 2, 2013 at 10:00 a.m. Eastern Time. The Company's first quarter 2013 financial results will be released after the market closes on Wednesday, May 1, 2013. During the conference call, Company officers will review first quarter performance, discuss recent events and conduct a question-and-answer period.

Teleconference Details: Members of the public who are interested in participating in the Company's first quarter earnings teleconference call should dial from the U.S., (877) 263-2989 , or from outside the U.S., (702) 928-7168 , shortly before 10:00 a.m. and reference the Apollo Commercial Real Estate Finance, Inc. Teleconference Call (number 32713157). Please note the teleconference call will be available for replay beginning at 12:00 p.m. on Thursday, May 2, 2013, and ending at midnight on Thursday, May 9, 2013. To access the replay, callers from the U.S. should dial (855) 859-2056 and callers from outside the U.S. should dial (404) 537-3406 , and enter conference identification number 32713157.

Webcast: The conference call will also be available on the Company's website at www.apolloreit.com . To listen to a live broadcast, please go to the site at least 15 minutes prior to the scheduled start time in order to register, download and install any necessary audio software. A replay of the call will also be available for 30 days on the Company's website.

About Apollo Commercial Real Estate Finance, Inc. Apollo Commercial Real Estate Finance, Inc. ( NYSE : ARI ) is a commercial mortgage real estate investment trust that primarily originates, invests in, acquires and manages senior and subordinate performing commercial real estate mortgage loans, commercial mortgage-backed securities and other commercial real estate-related debt investments throughout the U.S. The Company is externally managed and advised by ACREFI Management, LLC, a Delaware limited liability company and an indirect subsidiary of Apollo Global Management, LLC, a leading global alternative investment manager with approximately $113 billion of assets under management at December 31, 2012. 

Additional information can be found on the Company's website at www.apolloreit.com .

Forward-Looking Statements Certain statements contained in this press release constitute forward-looking statements as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such statements are intended to be covered by the safe harbor provided by the same. Forward-looking statements are subject to substantial risks and uncertainties, many of which are difficult to predict and are generally beyond the Company's control. These forward-looking statements include information about possible or assumed future results of the Company's business, financial condition, liquidity, results of operations, plans and objectives. When used in this release, the words "believe," "expect," "anticipate," "estimate," "plan," "continue," "intend," "should," "may" or similar expressions, are intended to identify forward-looking statements. Statements regarding the following subjects, among others, may be forward-looking: the return on equity; the yield on investments; the ability to borrow to finance assets; and risks associated with investing in real estate assets, including changes in business conditions and the general economy. For a further list and description of such risks and uncertainties, see the reports filed by the Company with the Securities and Exchange Commission. The forward-looking statements, and other risks, uncertainties and factors are based on the Company's beliefs, assumptions and expectations of its future performance, taking into account all information currently available to the Company. Forward-looking statements are not predictions of future events. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

CONTACT: Hilary Ginsberg (212) 822-0767

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Stewart Title's Leadership Changes Enhance Real Estate Services

Updated Category News Views 302

Stewart Title's Leadership Changes Enhance Real Estate Services Stewart Title is making significant leadership changes as part of its strategic approach to improve service offerings and expertise in the real estate transaction process. The company is recognized for its comprehensive services and deep expertise in residential and commercial title insurance, along with...

Continue Reading
Thoughtworks Joins DCfH2 Framework to Enhance Healthcare Solutions

Updated Category News Views 141

Thoughtworks Joins the DCfH2 Framework In a groundbreaking development, Thoughtworks has secured its position as a key supplier in the Digital Capability for Health 2 (DCfH2) framework. This prestigious framework is designed specifically for the UK Government's Public Health and Social Care programs. By integrating strategy, design, and engineering, Thoughtworks aims to...

Continue Reading
Simmons First National Corporation Sets Q3 2024 Earnings Call

Updated Category News Views 49

Simmons First National Corporation got set to drop its Q3 2024 earnings back in October, right before the market opened. Traders were buzzing because, honestly, these numbers can shake up the floor like an unexpected market quake. A well-established financial holding company with a long history of dividends is great on paper, but those digits tell the real...

Continue Reading
Alma Bank to Acquire American Community Bank

Updated Category News Views 22

Banking Shake-Up: Alma Bank's Bold Move Well, here we go again with another banking merger trying to make waves in the New York area. Alma Bank is swallowing up American Community Bank in an effort to broaden its horizons, specifically across New York and New Jersey. No big surprise there—these two have been eyeing potential synergies in complementary markets for a...

Continue Reading
Elastic N.V. Surpasses Expectations with Strong Q1 Results

Updated Category News Views 100

Elastic N.V. Reports Impressive Q1 Earnings Elastic N.V. (NYSE: ESTC) has recently experienced a significant boost in its market performance, attributed to their better-than-expected first-quarter results. The company's quarterly earnings reached 60 cents per share, exceeding the analyst consensus estimate of 42 cents per share. Furthermore, Elastic showcased robust...

Continue Reading